Michele Scotto di Mase

Papers

Total Citations

H-Index

About

Michele Scotto di Mase is a rising figure in biomedical engineering, whose work centers on the intersection of automation and cancer research. His primary research area is the development of high-throughput, automated microinjection systems for zebrafish xenograft models—a powerful tool for predicting patient-specific responses to cancer therapies. Scotto di Mase’s major contribution lies in addressing a critical bottleneck in this field: the labor-intensive and error-prone manual injection of cancer cells into fragile zebrafish larvae. By engineering automated solutions, he has significantly enhanced the precision, speed, and reproducibility of these assays, moving them closer to routine clinical diagnostic use. His most cited work, "Automated microinjection for zebrafish xenograft models" (2025), has already garnered 5 citations, underscoring its timely impact. This achievement is notable not only for its technical ingenuity but also for its potential to democratize personalized cancer diagnostics. As a researcher, Scotto di Mase is pioneering a path toward scalable, automated platforms that could transform how we evaluate cancer therapeutics, making him a key innovator to watch in the evolving landscape of translational oncology.